EMLA cream only

PreclinicalSmall molecule

DDamascus University

EMLA cream only is one of 19 small molecule programs targeting Anesthesia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnesthesiaCompleted

AnesthesiaPreclinical

Completed

Competition

Competitive Landscape

30 competitors in Anesthesia

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

10 2

Versed

CConrado Roberto Hoffmann Filho

Approved

4 3

Sufenta

LLeaf Vertical Inc.

Approved

4 4

Iheezo

BB. Braun Medical Inc.

Approved

3 5

Xylocaine

MMEDRx USA, Inc.

Phase 1

12 6

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 1

7 7

Duragesic

CCephalon

Preclinical

6 8

Romazicon

CConrado Roberto Hoffmann Filho

Preclinical

2 9

Ultram

WWim Janssens

Preclinical

1 10

Magnesium

SSpherium Biomed

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anesthesia1 trial

Enhancing the Efficiency of EMLA Cream in Palatal Anesthesia for Children

Completed·—·N/A·NCT05187494·75 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for EMLA cream only. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — EMLA cream only compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for EMLA cream only. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Damascus University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: DDamascus University

EMLA cream only

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anesthesia1 trial

References

Drug Info

Quick Facts

Related News